TCBIOMEDIUM SIGNALFINANCIAL10-K

TCBIO's annual filing reflects a meaningfully reduced capital expenditure footprint, declining operating cash flow, and a lower provision for credit losses, alongside a notable build in cash reserves.

The sharp pullback in capital expenditures — down roughly 80% — suggests the company has substantially curtailed investment activity, which could indicate either a completed build-out cycle or a more cautious posture toward growth spending. Operating cash flow declined approximately 25%, which warrants monitoring as it approaches the lower bound of the Medium signal threshold. The reduction in provision for credit losses by roughly 23% may reflect improved credit quality expectations, though investors should weigh this against the broader deceleration in cash generation.

Comparing 2026-02-10 vs 2025-02-11View on EDGAR →
FINANCIAL ANALYSIS

On the balance sheet, cash and equivalents grew meaningfully to $4.4B from $3.1B, a gain of approximately 44%, providing a stronger liquidity buffer. Offsetting this positive, operating cash flow contracted by 25.1% to $360.2M, and capital expenditures fell sharply to $12.6M from $64.8M, signaling a significant step-down in near-term investment. The provision for credit losses declined to $47.4M from $61.5M, a roughly 23% improvement, which is a modestly constructive credit quality signal — but the overall picture is one of a company conserving capital and generating less operational cash, trends investors should track closely in future periods.

FINANCIAL STATEMENT CHANGES
Capital Expenditure
Cash Flow
-80.6%
$64.8M→$12.6M

Capex reduced 80.6% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Cash & Equivalents
Balance Sheet
+43.7%
$3.1B→$4.4B

Cash position surged 43.7% — strong cash generation or capital raise providing significant financial cushion.

Revenue
P&L
-37.4%
$238K→$149K

Revenue declined 37.4% — significant demand weakness or market share loss warrants investigation.

Operating Cash Flow
Cash Flow
-25.1%
$481.1M→$360.2M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Provision for Credit Losses
P&L
-22.8%
$61.5M→$47.4M

Provisions reduced 22.8% — improving credit quality or reserve release boosting reported earnings.

LANGUAGE CHANGES
NEW — 2026-02-10
PRIOR — 2025-02-11
ADDED
There were 44,176,837 shares of the registrant s common stock outstanding on February 9, 2026.
Exhibits, Financial Statement Schedules 85 2 Forward-Looking Statements Certain statements and financial analysis contained in this report that are not historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, regarding, among other things, the Company s financial condition, results of operations, business plan and future performance.
These risks and uncertainties include, but are not limited to, those described in Part I, Item 1A.
Risk Factors, and elsewhere in this report and also as described from time to time in reports subsequently filed with the U.S.
You should read such information in conjunction with the Company s consolidated financial statements and related notes and Part II, Item 7.
Management s Discussion and Analysis of Financial Condition and Results of Operations.
There also may be other factors that the Company cannot anticipate or that are not described herein, generally because the Company does not currently perceive them to be material.
Such factors could cause results to differ materially from the Company s expectations.
You are advised, however, to review any further disclosures the Company make on related subjects in filings with the SEC and in other public statements.
The Company s business activities are conducted primarily through its wholly-owned bank subsidiary Texas Capital Bank (the Bank ) and its wholly-owned non-bank subsidiary, TCBI Securities Inc., doing business as Texas Capital Securities.
REMOVED
There were 46,012,977 shares of the registrant s common stock outstanding on February 10, 2025.
Exhibits, Financial Statement Schedules 87 2 Forward-Looking Statements Certain statements and financial analysis contained in this report that are not historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements may include, among other things and without limitation, statements about the credit quality of loan portfolio, liquidity, general economic conditions in the United States and in the Company s markets, including with respect to interest rates and the market generally, the material risks and uncertainties for the U.S.
and world economies, and for the business, expectations regarding rates of default and loan losses, volatility in the mortgage industry, business strategies (including new lines of business, products and services) and expectations about future financial performance, future growth and earnings, the appropriateness of the allowance for credit losses and provision for credit losses, the impact of changing regulatory requirements and legislative changes on the business, increased competition, and technologies (including new technologies and information security risks).
Economic or business conditions in Texas, the United States or globally that impact the Company or its customers.
Increased or expanded competition from banks and other financial service providers in Company markets.
The ability to successfully execute its business strategy, including developing and executing new lines of business and new products and services.
The ability to pursue and execute upon growth plans, whether as a function of capital, liquidity or other limitations.
The failure to identify, attract and retain key personnel and other employees.
The extensive regulations to which the Company and the Bank are subject and the Company and the Bank s ability to comply with applicable governmental regulations, including legislative and regulatory changes that may impose further restrictions and costs on the business, any regulatory enforcement actions that may be brought against us and the effect of changes in laws, regulations, policies and guidelines (including, among others, those concerning taxes, banking, accounting, securities and monetary and fiscal policies) with which the Company must generally comply.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →